{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-005501","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.061537+00:00","generated_at":"2026-05-17T19:10:04.872847+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cosmos Health secures up to $300M convertible note facility for Ethereum treasury strategy","bullets":["Up to $300M in 9% senior secured convertible notes; initial $8M close on Aug 6, 2025.","72.5% of net proceeds to be used to acquire Ethereum (ETH) as a digital asset treasury reserve.","Shares convertible at market-based pricing; beneficial ownership cap of 4.99% (can increase to 9.99%).","Company must call shareholder meeting within 60 days to approve increase in authorized shares to 1.5B.","Remaining proceeds for working capital, R&D, and U.S. manufacturing expansion; Curvature Securities placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-005501","json":"https://secwatch.observer/filing/0001477932-25-005501.json","markdown":"https://secwatch.observer/filing/0001477932-25-005501.md","text":"https://secwatch.observer/filing/0001477932-25-005501.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/0001477932-25-005501-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:10:04.872847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c2522fa7abef77da3cb407521ab9438cd68a21b","claim":"Cosmos Health Inc. incurred convertible notes of $300,000,000 with an institutional investor at 9% per annum maturing twenty four (24) months after its respective issuance date.","evidence_excerpt":"the Company agreed to issue and sell to the Purchaser a series of 9% original issue discount senior secured convertible promissory notes (each, a “ Note ” and collectively, the “ Notes ”) in the maximum aggregate principal amount of $300,000,000 (the “ Note Offering ”)","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/0001477932-25-005501-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$300,000,000"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Rate","value":"9% per annum"},{"label":"Maturity","value":"twenty four (24) months after its respective issuance date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}